MissionIR Articles

Athersys is a clinical stage biopharm company growing a pipeline of highly differentiated therapeutics to treat significant and life-threatening diseases. The company’s current product development portfolio consists of MultiStem®, a proprietary stem cell product for…

OncoSec Medical is a biotech company focused on the development of treatments addressing advanced-stage skin cancer, specifically: melanoma, Merkel cell lymphoma and cutaneous T-cell lymphoma. ONCS’ proprietary technology, OncoSec Medical System™ (OMS), is based on…

Neuralstem, a development-stage company focused on the development and commercialization of treatments for central nervous system disease, has developed and maintains a portfolio of patents and patent applications that form base for its research and…

ProMetic Life Sciences operates through a group of subsidiaries to specialize in the design of small molecules that mimic unique and specific interactions between proteins. The company’s technologies are applicable to large-scale drug purification, drug…

NovaBay Pharmaceuticals is a clinical-stage biotech company focused on the development of its proprietary and patented Aganocide® compounds. NBY focuses its technology on four therapeutic areas: dermatology, ophthalmology, urology and hospital infections. The company has…

Shire is a biopharmaceutical company that focuses its business on attention deficit hyperactivity disorder, human genetic therapies, gastrointestinal diseases and regenerative medicine as well as opportunities in other therapeutic areas. SHPG’s in-licensing, merger and acquisition…

Organovo Holdings focuses on breakthrough 3D biology capabilities to create tissue on-demand for research and surgical applications. The company’s NovoGen MMX Bioprinter™ is the world’s only commercial bioprinter with the proven ability to create tissue.…

Resverlogix is a clinical stage cardiovascular company with an epigenetic platform technology that modulates protein production. The company is developing RVX-208 for the treatment of atherosclerosis. RVX’s business model is to seek strategic opportunities through…

Cytori Therapeutics is a medical technologies company focused on the potential of adult stem cell and regenerative cells from adipose tissue. The company’s Celution® System family of medical devices and instruments is being sold into…

Sucampo Pharmaceuticals is a global pharmaceutical company engaged in the development and commercialization of medicines based on prostones, a class of compounds occurring naturally in the body. The company is focused on developing prostone-based compounds…

Bio-Path Holdings is a biotech company focused on developing therapeutic products utilizing its proprietary liposomal delivery technology, which was designed to systemically distribute nucleic acid drugs throughout the human body via intravenous infusion. BPTH is…

ReNeuron Group is engaged in the research, development and commercial exploitation of stem cell technologies for therapeutic and non-therapeutic applications worldwide. Its lead therapeutic candidate is ReN001 stem cell therapy, which is in clinical development…

Inovio Pharmaceuticals is engaged in the development of synthetic vaccines, with a focus on cancers and infectious diseases. The company’s SynCon technology enables the design of universal vaccines capable of providing cross-protection against pathogens, such…

Advanced Cell Technology is a biotech company that applies stem cell-based technologies (both adult and human embryonic) and other proprietary methods in the field of regenerative medicine. ACTC is also developing therapeutic platforms using corneal…

Avita Medical develops and distributes regenerative and tissue-engineered products for the treatment of a broad range of wounds, scars and skin defects. The company’s lead product, ReCell® Spray-On Skin™, is CE-marked for Europe, TGA-registered in…

Amorfix Life Sciences is a theranostics company developing therapeutic products and diagnostic devices targeting misfolded protein diseases including ALS, cancer and Alzheimer’s Disease. The company offers two types of products: therapeutics, designed to target and…

RXi Pharmaceuticals is a biotech company focused on discovering, developing and commercializing innovative therapies based on its proprietary, next-generation RNAi platform. RXi’s first RNAi product candidate, RXI-109, entered into RXi’s first human clinical trial in…

ERBA Diagnostics is an emerging company in the global healthcare industry, operating in the core business segment of In Vitro Diagnostics (IVD). ERB’s product range includes a wide range of Clinical Chemistry Analyzers (Photometers &…

Viropro, through its subsidiaries, engages in the contract research, development, and manufacturing of biotherapeutic proteins for the treatment of various diseases. The company is also involved in the transfer of its proprietary technologies for industrial…

Addex Therapeutics focuses on the discovery and development of an emerging class of oral small molecule drugs that can be exquisitely selective for their intended target and confer significant therapeutic advantages over conventional “orthosteric” small…

Alliqua is a biomedical company focused on the development, manufacturing and marketing of its own proprietary products based on the company’s existing technology portfolio. ALQA currently markets its own proprietary brands of wound dressings: SilverSeal®…

Cyclacel Pharmaceuticals is a biopharmaceutical company developing oral therapies for the treatment of cancer and other serious diseases. The company has three product candidates are currently in clinical development: Sapacitabine (CYC682) for the treatment of…